Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (201-210 of 350) with videos related to

Pageof 35
Sort By:
Acta Neuropathologica|January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Neuro-Oncology|August 15, 2018
Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with gliomaMiguel Angel Tejada Neyra, Ulf Neuberger, Annekathrin Reinhardt, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Thyroid : Official Journal of the American Thyroid Association|January 15, 2014
Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assaysMarius I Ilie, Sandra Lassalle, Elodie Long-Mira, et al.
The American Journal of Surgical Pathology|September 22, 2023
A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic ProfileAmos Muench, Daniel Teichmann, Dorothee Spille, et al.
Genome Medicine|March 1, 2022
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumorsTincy Simon, Pamela Riemer, Armin Jarosch, et al.
Acta Neuropathologica|October 24, 2015
Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
The American Journal of Surgical Pathology|June 26, 2013
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndromeChristopher W Toon, Michael D Walsh, Angela Chou, et al.
Pageof 35

Showing results (201-210 of 350) with videos related to

Sort By:
Pageof 35
Acta Neuropathologica|January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Neuro-Oncology|August 15, 2018
Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with gliomaMiguel Angel Tejada Neyra, Ulf Neuberger, Annekathrin Reinhardt, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Thyroid : Official Journal of the American Thyroid Association|January 15, 2014
Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assaysMarius I Ilie, Sandra Lassalle, Elodie Long-Mira, et al.
The American Journal of Surgical Pathology|September 22, 2023
A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic ProfileAmos Muench, Daniel Teichmann, Dorothee Spille, et al.
Genome Medicine|March 1, 2022
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumorsTincy Simon, Pamela Riemer, Armin Jarosch, et al.
Acta Neuropathologica|October 24, 2015
Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
The American Journal of Surgical Pathology|June 26, 2013
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndromeChristopher W Toon, Michael D Walsh, Angela Chou, et al.
Pageof 35